FOSL1 and head and neck squamous cell carcinoma: Oncogenic transcription factor (FOSL1) can regulate EMT in a variety of tumors (Sobolev et al., 2022),synergizes with PDL-1 in HNSCC, and significantly inhibits EMT through the ERK1/2/FOSL1 pathway (Luo et al., 2022).